Western blotting of total lysate of Helicobacter pylori in cases of atrophic body gastritis

Clinical Chemistry

Volumn 52, Issue 2, 2006, Pages 220-226

  Mini, Roberta ^a   Annibale, Bruno ^b   Lahner, Edith ^b   Bernardini, Giulia ^a   Figura, Natale ^a   Santucci, Annalisa ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM LYSATE;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CHRONIC GASTRITIS; DISEASE COURSE; DYSPLASIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; IMMUNOBLOTTING; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; SERODIAGNOSIS; STOMACH CARCINOGENESIS; STRAIN DIFFERENCE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 31844442368     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.054627     Document Type: Article

References (40)

1. Lee EL, Feldman M. Gastritis and other gastropathies. In: Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management, 7th ed. Philadelphia: WB Saunders, 2002:810-27.
2. Peterson WL, Graham DY. Helicobacter pylori. In: Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management, 7th ed. Philadelphia: WB Saunders, 2002:732-46.
3. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19(Suppl):S37-43.
4. Ming SC. Cellular and molecular pathology of gastric carcinoma and precursor lesions: a critical review. Gastric Cancer 1998;1:31-50.
5. Fong TL, Dooley CP, Dehesa M, Cohen H, Carmel R, Fitzgibbons PL, et al. Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology 1991;100:328-32.
6. Karnes WE, Samloff IM, Siurala M, Kekki M, Sipponen P, Kim SW, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-74.
7. Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
8. Malfertheiner P, Mégraud F, O'Morain C, Hungin AP, Jones R, Axon ATR, et al.; European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection: the Maastricht 2-2000 Consensus Report [Review]. Aliment Pharmacol Ther 2002;16:167-80.
9. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997;6:639-42.
10. Annibale B, Negrini R, Caruana P, Lahner E, Grossi C, Bordi C, et al. Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection. Helicobacter 2001;6:225-33.
11. 13C-urea breath test, and serology. Scand J Gastroenterol 2000;35:138-41.
12. Kokkola A, Rautelin H, Puolakkainen P, Sipponen P, Farkkila M, Haapiainen R, et al. Positive result by serology indicates active Helicobacter, pylori infection in patients with atrophic gastritis. J Clin Microbiol 1998;36:1808-10.
13. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15-24.
14. Annibale B, Aprile MR, D'Ambra G, Caruana P, Bordi C, Delle Fave G. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 2000;14:625-34.
15. Kokkola A, Sipponen P, Rautelin H, Harkonen M, Kosunen TU, Haapiainen R, et al. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment Pharmacol Ther 2002;16:515-20.
16. Faisal MA, Russell RM, Samloff IM, Holt PR. Helicobacter pylori infection and atrophic gastritis in the elderly. Gastroenterology 1990;99:1543-4.
17. Liston R, Pitt MA, Banerjee AK. IgG ELISA antibodies and detection of Helicobacter pylori in elderly patients. Lancet 1996;347:269-70.
18. Lahner E, Bordi C, Di Giulio E, Caruana P, D'Ambra G, Milione M, et al. Role of Helicobacter pylori serology in atrophic body gastritis after eradication treatment. Aliment Pharmacol Ther 2002;16:507-14.
19. Annibale B, Di Giulio E, Caruana P, Lahner E, Capurso G, Bordi C, et al. The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis. Aliment Pharmacol Ther 2002;16:1723-31.
20. Satoh K, Kimura K, Taniguchi Y, Kihira K, Takimoto T, Saifuku K, et al. Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis. Am J Gastroenterol 1998;93:569-73.
21. Leammli UK. Cleavage of structural proteins during assembly of head of bacteriophage T4. Nature 1970;227:680-3.
22. Santucci A, Trabalzini L, Bovalini L, Neri P, Martelli P. Differences between predicted and observed sequences in Saccharomyces cerevisiae. Electrophoresis 2000;21:37123-71.
23. Hochstrasser DF, Patchornik A, Merril CR. Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining. Anal Biochem 1988;173:412-23.
24. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996;20:1161-81.
25. Ho B, Marshall BJ. Accurate diagnosis of Helicobacter pylori. Serologic testing. Gastroenterol Clin North Am 2000;29:853-62.
26. Towbin H, Stahelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4.
27. Kokkola A, Kosunen TU, Puolakkainen P, Sipponen P, Harkonen M, Laxen F, et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 2003;111:619-24.
28. Stoicov C, Saffari R, Cai X, Hasyagar C, Houghton J. Molecular biology of gastric cancer: Helicobacter infection and gastric adenocarcinoma: bacterial and host factors responsible for altered growth signaling. Gene 2004;341:1-17.
29. Sorberg M, Engstrand L, Strom M, Jonsson KA, Jorbeck H, Granstrom M. The diagnostic value of enzyme immunoassay and immunoblot in monitoring eradication of Helicobacter pylori. Scand J Infect Dis 1997;29:147-51.
30. Jungblut PR. Proteome analysis of bacterial pathogens. Microbes Infect 2001;3:8831-40.
31. Lepper PM, Moricke A, Vogt K, Bode G, Trautmann M. Comparison of different criteria for interpretation of immunoglobulin G immunoblotting results for diagnosis of Helicobacter pylori infection. Clin Diagn Lab Immunol 2004;11:569-76.
32. Jungblut PR, Bumann D, Haas G, Zimny-Arndt U, Holland P, Lamer S, et al. Comparative proteome analysis of Helicobacter pylori. Mol Microbiol 2000;36:710-25.
33. Voland P, Weeks DL, Vaira D, Prinz C, Sachs G. Specific identification of three low molecular weight membrane-associated antigens of Helicobacter pylori. Aliment Pharmacol Ther 2002;16:533-44.
34. Genta RM. Helicobacter pylori, inflammation, mucosal damage, and apoptosis: pathogenesis and definition of gastric atrophy. Gastroenterology 1997;113(Suppl 6):S51-5.
35. Lahner E, Vaira D, Figura N, Pilozzi E, Pasquali A, Severi C, et al. Role of noninvasive tests (C-urea breath test and stool antigen test) as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis. Helicobacter 2004;9:436-42.
36. Kamada T, Haruma K, Hata J, Kusunoki H, Sasaki A, Ito M, et al. The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis. Aliment Pharmacol Ther 2003;18:245-52.
37. Cutler AF, Havstad S, Ma CK, Blaser MJ, Perez-Perez GI, Schubert TT. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995;109:136-41.
38. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection. J Clin Pathol 1991;44:326-8.
39. Kosunen TU, Seppala K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-5.
40. Ekstrom AM, Held M, Hansson LE, Engstfand L, Nyren O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001;121:784-91.